The effect of loperamide on deoxycholic acid (DOC)-induced secretion was studied in ligated loops of the rat jejunum and colon in vivo. In controls, loperamide slightly augmented fluid absorption. 3 mmol DOC caused net fluid secretion. Loperamide reduced this secretion in the colon and reversed it to absorption in the jejunum. Na-K-ATPase specific activity and cAMP levels were measured in the jejunum, and [14C]erythritol clearance as an index of mucosal permeability in the colon. In the jejunum this opiate analogue affected neither basal or DOC-depressed Na-K-ATPase, nor mucosal cAMP. In the colon it reduced a large increase of the erythritol clearance caused by DOC. It is suggested that loperamide interferes with DOC-induced intestinal secretion in part by lowering mucosal permeability.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF00495957 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of konjac glucomannan on metabolites in the stomach, small intestine and large intestine of constipated mice and prediction of the KEGG pathway.
Food Funct
April 2021
College of Food Science, Southwest University, Chongqing 400715, China.
Article Synopsis
- The study investigates the effects of konjac glucomannan (KGM) on constipation in mice, aiming to understand its mechanism for promoting excretion throughout the gastrointestinal tract.
- Results showed that KGM improved fecal water content and body weight growth, as well as altered metabolic profiles by decreasing certain amino acids and increasing others.
- KGM's beneficial effects on constipation are likely due to its influence on biosynthesis and metabolism pathways involving amino acids and fatty acids, revealing potential targets for treatment.
Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature.
World J Gastroenterol
June 2018
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus C 8000, Denmark.
Bile acid diarrhea results from excessive amounts of bile acids entering the colon due to hepatic overexcretion of bile acids or bile acid malabsorption in the terminal ileum. The main therapies include bile acid sequestrants, such as colestyramine and colesevelam, which may be given in combination with the opioid receptor agonist loperamide. Some patients are refractory to conventional treatments.
View Article and Find Full Text PDFssp. GCL2505 has been shown to proliferate in the human intestine. The intestinal dynamics and physiological effects of GCL2505 as well as the mechanism underlying proliferation in the gut were investigated.
View Article and Find Full Text PDFA new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load.
J Pharm Biomed Anal
December 2013
Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
A non-invasive test for oro-ileal transit time (OITT) evaluation was developed, based on the measurement of tauroursodeoxycholic acid (TUDCA) oral fluid concentration profile after its oral administration. Exploiting the fact that TUDCA is actively absorbed only in the ileum, OITT is measured as the time corresponding to TUDCA maximum oral fluid concentration (tmax). To measure oral fluid TUDCA concentration in a point-of-care setting, an ultrasensitive portable immunosensor was developed, based on a competitive chemiluminescent enzyme immunoassay (CL-EIA), using immobilized anti-TUDCA antibody and an ursodeoxycholic acid (UDCA)-peroxidase conjugate as tracer, detected by enhanced chemiluminescence employing a portable charge-coupled device (CCD)-based device.
View Article and Find Full Text PDFInhibition by loperamide of mucus secretion in the rat colon in vivo.
Eur J Pharmacol
October 1989
Medizinische Klinik Innenstadt, University of Munich, F.R.G.
The effect of loperamide on mucus secretion and the net transport of fluid, sodium and potassium was investigated in the perfused rat colon in vivo. Prostaglandin E2 (PGE2, 1 mg/kg per h intraarterially) and deoxycholic acid (2 mM intraluminally) were used as secretagogues. Mucus secretion was determined as the total amount of protein-bound hexose in the effluent.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!